The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Bromo-N-(4-((2-(piperazin-1-yl)pyrimidin-4-yl)amino)phenyl)benzenesulfonamide hydrochloride ID: ALA4781610
PubChem CID: 162664739
Max Phase: Preclinical
Molecular Formula: C20H22BrClN6O2S
Molecular Weight: 489.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cl.O=S(=O)(Nc1ccc(Nc2ccnc(N3CCNCC3)n2)cc1)c1ccc(Br)cc1
Standard InChI: InChI=1S/C20H21BrN6O2S.ClH/c21-15-1-7-18(8-2-15)30(28,29)26-17-5-3-16(4-6-17)24-19-9-10-23-20(25-19)27-13-11-22-12-14-27;/h1-10,22,26H,11-14H2,(H,23,24,25);1H
Standard InChI Key: GAEMPQNKYOKFIM-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 33 0 0 0 0 0 0 0 0999 V2000
37.9539 -10.0515 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.2535 -8.1425 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.9525 -7.7114 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2314 -7.3268 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.9896 -10.1509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4147 -10.8516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2321 -10.8329 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.6255 -10.1142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1954 -9.4129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3794 -9.4351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4427 -10.0976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8634 -10.8017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6771 -10.7871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0752 -10.0728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6534 -9.3716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8335 -9.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9493 -8.7376 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1324 -8.7614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7086 -8.0653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8925 -8.0887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5039 -8.8085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9373 -9.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7519 -9.4795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6857 -8.8361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4368 -8.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0077 -7.4760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1917 -7.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8064 -8.2247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2430 -8.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0576 -8.8899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9902 -8.2521 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
3 2 2 0
2 4 2 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
10 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 2 1 0
2 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
28 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 489.40Molecular Weight (Monoisotopic): 488.0630AlogP: 3.19#Rotatable Bonds: 6Polar Surface Area: 99.25Molecular Species: BASEHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.11CX Basic pKa: 8.83CX LogP: 2.73CX LogD: 2.32Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.49Np Likeness Score: -1.71
References 1. Zhang Q,Wu X,Zhou J,Zhang L,Xu X,Zhang L,You Q,Wang L. (2021) Design, synthesis and bioevaluation of inhibitors targeting HSP90-CDC37 protein-protein interaction based on a hydrophobic core., 210 [PMID:33109397 ] [10.1016/j.ejmech.2020.112959 ]